Each square gives extinction probability p (AB) or median population change d (CD) for 100 simulations at . by Alexandra M. Campbell (3284094)

Subjects:

Lifespan of a single <i>T. utriculata</i> rosette. by Alexandra M. Campbell (3284094)

Subjects:

Characteristics of patients who received dementia care before and after COVID-19-related regulatory changes in hospitals that received COVID-19-positive patients. by Takuya Okuno (9931900)

Characteristics of patients who received dementia care before and after COVID-19-related regulatory changes in hospitals that received no COVID-19-positive patients. by Takuya Okuno (9931900)

Changes in the proportion of initial treatments received by non-COVID-19 ICU patients (IMV and vasopressors). by Shusuke Watanabe (13863801)

VBPBB and GSBB 95% confidence intervals for the smallest and largest values in each confidence band. by Megan Di Maio (19556597)

The top 10 putative metabolites with the largest negative fold change between normal and thin cows. by Bhuripit Saraphol (20855573)

The top 10 putative metabolites with the largest positive fold change between normal and thin cows. by Bhuripit Saraphol (20855573)

Preparatory neuronal activity in ALM is decreased, but remains significant in quiet trials devoid of movements. by Vahid Esmaeili (12700352)

Attitude change toward IT innovations after receiving a designed message (<i>D</i>) by age. by Hidenori Komatsu (8313705)

Subjects:

Attitude change toward IT innovations after receiving a designed message (<i>D</i>) by sex. by Hidenori Komatsu (8313705)

Subjects:

Illustration of the statistical evaluation of the received questionnaires. by Nathalie Mathern (10826506)

Illustration of the statistical evaluation of the received questionnaires. by Nathalie Mathern (10826506)

Forest plots illustrating mean and 95% confidence interval change in the outcome measure in patients receiving treatment compared with placebo. by Stephen D. Auger (22470045)

Study Data. by Jonathan S. Jahr (2709088)

“…Patients were grouped into those that had or had not received dexamethasone as prophylaxis for PONV prior to the administration of sugammadex, and heart rate changes were evaluated 5 minutes after sugammadex administration. …”

Study outcomes. by Jonathan S. Jahr (2709088)

“…Patients were grouped into those that had or had not received dexamethasone as prophylaxis for PONV prior to the administration of sugammadex, and heart rate changes were evaluated 5 minutes after sugammadex administration. …”

Patient characteristics. by Jonathan S. Jahr (2709088)

“…Patients were grouped into those that had or had not received dexamethasone as prophylaxis for PONV prior to the administration of sugammadex, and heart rate changes were evaluated 5 minutes after sugammadex administration. …”

Fig 2 - by Stefan Partelow (8416011)

Pattern of PFT parameters %predicted value changes among the participants who received bronchodilator. by Abu Bakar Siddik (10032406)

Proportion of the increase (green) or decrease (red) in forest cover in areas with different fire recurrences in Africa, according to the Mann-Kendall test and statistically signif... by Oswaldo Maillard (20660661)